Breakthrough gene therapy allows 11-year-old boy to hear for the first time

Aissam Dam, an 11-year-old boy born deaf, underwent a successful clinical trial for gene therapy to treat his congenital deafness. The therapy aims to replace the mutated otoferlin gene with a functional one. This groundbreaking study, supported by Eli Lilly, could pave the way for gene therapies targeting other forms of congenital deafness.